Annual ROE
338.32%
+636.42%+213.49%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual return on equity is 338.32%, with the most recent change of +636.42% (+213.49%) on December 31, 2022.
- During the last 3 years, ELOX annual ROE has risen by +478.81% (+340.81%).
- ELOX annual ROE is now at all-time high.
Performance
ELOX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
124.90%
-68.23%-35.33%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly return on equity is 124.90%, with the most recent change of -68.23% (-35.33%) on September 30, 2023.
- Over the past year, ELOX quarterly ROE has increased by +666.47% (+123.06%).
- ELOX quarterly ROE is now -98.14% below its all-time high of 6728.54%, reached on December 31, 2022.
Performance
ELOX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ELOX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +213.5% | +123.1% |
| 3 y3 years | +340.8% | +176.2% |
| 5 y5 years | +440.7% | +211.0% |
ELOX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +213.5% | -98.1% | +123.1% |
| 5 y | 5-year | at high | +200.1% | -98.1% | +123.1% |
| alltime | all time | at high | +150.8% | -98.1% | +105.5% |
Eloxx Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | 124.90%(-35.3%) |
| Jun 2023 | - | 193.13%(-52.6%) |
| Mar 2023 | - | 407.33%(-93.9%) |
| Dec 2022 | 338.32%(-213.5%) | 6728.54%(-1342.4%) |
| Sep 2022 | - | -541.57%(+110.9%) |
| Jun 2022 | - | -256.75%(-0.7%) |
| Mar 2022 | - | -258.67%(-4.3%) |
| Dec 2021 | -298.10%(-11.8%) | -270.22%(-3.7%) |
| Sep 2021 | - | -280.60%(-16.2%) |
| Jun 2021 | - | -334.76%(+38.0%) |
| Mar 2021 | - | -242.61%(+26.0%) |
| Dec 2020 | -338.00%(+140.6%) | -192.48%(+17.5%) |
| Sep 2020 | - | -163.87%(+13.1%) |
| Jun 2020 | - | -144.83%(+11.5%) |
| Mar 2020 | - | -129.89%(+9.2%) |
| Dec 2019 | -140.49%(+27.8%) | -118.94%(-0.8%) |
| Sep 2019 | - | -119.84%(+6.9%) |
| Jun 2019 | - | -112.06%(+4.7%) |
| Mar 2019 | - | -107.06%(-4.8%) |
| Dec 2018 | -109.96%(+10.7%) | -112.49%(+41.2%) |
| Sep 2018 | - | -79.66%(-12.4%) |
| Jun 2018 | - | -90.95%(-54.8%) |
| Mar 2018 | - | -201.21%(-21.1%) |
| Dec 2017 | -99.31%(-85.1%) | - |
| Sep 2017 | - | -255.06%(+9.2%) |
| Jun 2017 | - | -233.63%(+60.9%) |
| Jun 2017 | -665.34%(+575.2%) | - |
| Mar 2017 | - | -145.21%(+1.6%) |
| Dec 2016 | - | -142.89%(-10.7%) |
| Sep 2016 | - | -159.99%(+52.1%) |
| Jun 2016 | -98.54%(+8.3%) | -105.21%(+28.2%) |
| Mar 2016 | - | -82.07%(+50.6%) |
| Dec 2015 | - | -54.51%(-41.3%) |
| Sep 2015 | - | -92.89%(-12.3%) |
| Jun 2015 | -90.97%(+54.2%) | -105.90%(-15.7%) |
| Mar 2015 | - | -125.69%(-8.3%) |
| Dec 2014 | - | -137.00%(+51.0%) |
| Sep 2014 | - | -90.74%(+0.2%) |
| Jun 2014 | -58.99%(-65.1%) | -90.59%(-35.2%) |
| Mar 2014 | - | -139.89%(-16.1%) |
| Dec 2013 | - | -166.64%(-23.1%) |
| Sep 2013 | - | -216.81%(+4.5%) |
| Jun 2013 | -169.15%(+33.1%) | -207.39%(+14.7%) |
| Mar 2013 | - | -180.78%(-6.8%) |
| Dec 2012 | - | -193.93%(+10.7%) |
| Sep 2012 | - | -175.17%(+33.7%) |
| Jun 2012 | -127.12%(+9.3%) | -131.00%(-5.8%) |
| Mar 2012 | - | -139.13%(+3.7%) |
| Dec 2011 | - | -134.20%(+24.9%) |
| Sep 2011 | - | -107.46%(-1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | -116.32%(-40.7%) | -109.06%(-41.3%) |
| Mar 2011 | - | -185.64%(-33.3%) |
| Dec 2010 | - | -278.30%(-11.1%) |
| Sep 2010 | - | -313.09%(+6.4%) |
| Jun 2010 | -196.11%(+165.4%) | -294.18%(+45.1%) |
| Mar 2010 | - | -202.73%(+146.4%) |
| Dec 2009 | - | -82.27%(+18.3%) |
| Sep 2009 | - | -69.55%(-4.9%) |
| Jun 2009 | -73.88%(+0.5%) | -73.10%(+17.3%) |
| Mar 2009 | - | -62.31%(-9.9%) |
| Dec 2008 | - | -69.13%(-4.0%) |
| Sep 2008 | - | -72.04%(-2.4%) |
| Jun 2008 | -73.48%(-36.3%) | -73.79%(-17.9%) |
| Mar 2008 | - | -89.83%(+23.9%) |
| Dec 2007 | - | -72.53%(-21.5%) |
| Sep 2007 | - | -92.44%(-11.9%) |
| Jun 2007 | -115.28%(+48.5%) | -104.87%(+3.9%) |
| Mar 2007 | - | -100.94%(+8.3%) |
| Dec 2006 | - | -93.18%(+12.6%) |
| Sep 2006 | - | -82.75%(+6.8%) |
| Jun 2006 | -77.62%(+34.5%) | -77.50%(+4.1%) |
| Mar 2006 | - | -74.44%(-4.6%) |
| Dec 2005 | - | -78.06%(+8.1%) |
| Sep 2005 | - | -72.19%(+4.8%) |
| Jun 2005 | -57.73%(-41.2%) | -68.86%(-15.2%) |
| Mar 2005 | - | -81.17%(+9.6%) |
| Dec 2004 | - | -74.07%(-12.6%) |
| Sep 2004 | - | -84.78%(-24.2%) |
| Jun 2004 | -98.24%(+81.7%) | -111.83%(+10.5%) |
| Mar 2004 | - | -101.21%(-9.4%) |
| Dec 2003 | - | -111.69%(+25.9%) |
| Sep 2003 | - | -88.69%(+64.2%) |
| Jun 2003 | -54.08%(-36.2%) | -54.01%(+10.2%) |
| Mar 2003 | - | -49.02%(-1.8%) |
| Dec 2002 | - | -49.92%(-24.7%) |
| Sep 2002 | - | -66.26%(-30.2%) |
| Jun 2002 | -84.71%(-70.4%) | -94.90%(-46.6%) |
| Mar 2002 | - | -177.58%(-51.2%) |
| Dec 2001 | - | -363.69%(-55.5%) |
| Sep 2001 | - | -816.46%(+180.1%) |
| Jun 2001 | -286.16%(+42.2%) | -291.54%(-3.7%) |
| Mar 2001 | - | -302.77%(-18.0%) |
| Dec 2000 | - | -369.28%(+2.2%) |
| Sep 2000 | - | -361.27%(+1.1%) |
| Jun 2000 | -201.17%(+57.0%) | -357.49%(-84.1%) |
| Mar 2000 | - | -2251.74%(+350.3%) |
| Dec 1999 | - | -500.00% |
| Jun 1999 | -128.15%(-138.2%) | - |
| Jun 1998 | 335.48%(+50.5%) | - |
| Jun 1997 | 222.86% | - |
FAQ
- What is Eloxx Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual ROE year-on-year change?
- What is Eloxx Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly ROE year-on-year change?
What is Eloxx Pharmaceuticals annual return on equity?
The current annual ROE of ELOX is 338.32%
What is the all time high annual ROE for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual return on equity is 338.32%
What is Eloxx Pharmaceuticals annual ROE year-on-year change?
Over the past year, ELOX annual return on equity has changed by +636.42% (+213.49%)
What is Eloxx Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ELOX is 124.90%
What is the all time high quarterly ROE for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly return on equity is 6728.54%
What is Eloxx Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ELOX quarterly return on equity has changed by +666.47% (+123.06%)